Put Options Transactions Made in Q3 2024 in Biocryst Pharmaceuticals Inc (BCRX)
This table provides information about the institutional ownership of Biocryst Pharmaceuticals Inc (BCRX) during Q3 2024. The information is specifically focused on institutions that hold put options of BIOCRYST PHARMACEUTICALS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
PUT |
462KNew |
$2.96M - $4.02M
|
462K
$3.5M
|
|
|
Nov 15, 2024
Q3 2024
|
Barclays PLC
London, X0 |
BUY
|
PUT |
10KNew |
$64.1K - $86.9K
|
10K
$75.7K
|
|
|
Nov 14, 2024
Q3 2024
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
PUT |
3.1KNew |
$19.9K - $26.9K
|
3.1K
$23.5K
|
|
|
Nov 14, 2024
Q3 2024
|
Wolverine Trading, LLC
Chicago, IL |
BUY
|
PUT |
100+ 0.33% |
$641 - $869
|
30.1K
$228K
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
PUT |
-23.7K- 22.03% |
$152K - $206K
|
83.9K
$635K
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
PUT |
-70.5K- 33.24% |
$452K - $613K
|
142K
$1.07M
|